Atai Life Sciences has identified monoamine transporter modulators reported to be useful for the treatment of post-traumatic stress, eating disorders and obsessive-compulsive disorder.
The country’s New Year celebration for 2025 saw one dead and 381 injured, the Office of Civil Defense (OCD) reported on Saturday. According to the agency’s latest situation report, the death was ...
Chicago, Illinois - IV Solution & Ketamine Centers of Chicago is expanding its mental health care program. This expansion focuses on innovative treatments for tough conditions lik ...
Biohaven Ltd. (NYSE: BHVN) today announced that Vlad Coric, M.D., Chairman and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis ...